
Vivos Announces Strong Momentum and Revenue Growth Prospects in 2024
Vivos Therapeutics, Inc. (the “company” or “Vivos”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective

